RaQualia Pharma Inc.

Research RaQualia Pharma Inc. (4579.T) with Bullrun company financials, valuation charts, model signals, and historical stock context.

Key Metrics

Ticker4579.T
ExchangeTSE
CountryJapan
CurrencyJPY
Financial periodFY2025
RevenueJPY 3.98B
Revenue growth28.1%
Net incomeJPY 273.12M
Free cash flow-JPY 429.09M
Gross margin82.1%

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	JPY 3.98B	JPY 273.12M	-JPY 429.09M	82.1%	11.36	JPY 3.24B	JPY 2.90B	JPY 6.90B
FY2024	JPY 3.11B	-JPY 495.03M	JPY 65.05M	79.9%	-22.87	JPY 3.34B	JPY 3.45B	JPY 5.57B
FY2023	JPY 1.90B	-JPY 323.66M	-JPY 940.80M	87.1%	-14.98	JPY 3.71B	JPY 367.72M	JPY 6.12B
FY2022	JPY 2.92B	JPY 723.39M	JPY 1.45B	92.1%	34.47	JPY 3.68B	JPY 222.34M	JPY 5.50B

Related stock research

Japan stocks A-Z stock index

Other related stocks

M3, Inc. (2413.T) Human Holdings Co., Ltd. (2415.T) TSUKADA GLOBAL HOLDINGS Inc. (2418.T) ROXX,inc. (241A.T) Brass Corporation (2424.T) Care Service Co.,Ltd. (2425.T) Wellnet Corporation (2428.T) World Holdings Co., Ltd. (2429.T) DeNA Co., Ltd. (2432.T) Hakuhodo DY Holdings Inc (2433.T) CEDAR.Co.,Ltd. (2435.T) Kyodo Public Relations Co., Ltd. (2436.T)